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Morbidity and mortality associated with bacterial meningitis remain high, although antibiotic
therapy has improved during recent decades. The major intracranial complications of bacterial
meningitis are cerebrovascular arterial and venous involvement, brain edema, and hydrocephalus
with a subsequent increase of intracranial pressure. Experiments in animal models and cell
culture systems have focused on the pathogenesis and pathophysiology of bacterial meningitis in
an attempt to identify the bacterial and/or host factors responsible for brain injury during the
course of infection. An international workshop entitled "Bacterial Meningitis: Mechanisms of
Brain Injury" was organized by the Department of Neurology at the University of Munich and
was held in Eibsee, Germany, in June 1993. This conference provided a forum for the exchange
of current information on bacterial meningitis, including data on the clinical spectrum of compli-
cations, the associated morphological alterations, the role of soluble inflammatory mediators (in
particular cytokines) and of leukocyte-endothelial cell interactions in tissue injury, and the mo-
lecular mechanisms of neuronal injury, with potential mediators such as reactive oxygen species,
reactive nitrogen species, and excitatory amino acids. It is hoped that a better understanding of
the pathophysiological events that take place during bacterial meningitis will lead to the develop-
ment of new therapeutic regimens.
Although the recent licensure of Haeniophilus influenzae
type b (Hib) polysaccharide conjugate protein vaccines has
had a marked impact on the incidence of invasive Hib dis-
ease in the United States and Western Europe. bacterial men-
ingitis overall remains a significant problem worldwide. In
addition, despite the introduction of new antimicrobial
agents and improved diagnostic techniques, the mortality
and morbidity associated with bacterial meningitis remain
unacceptably high. This discrepancy between a rapid bacteri-
ologic response at the site of infection (i.e .. eradication of
viable bacteria from the CSF due to treatment with potent
bactericidal agents) and the persistence of the associated neu-
rological sequelae and mortality has prompted intense inves-
tigation over the past two decades into the pathophysiology
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of this disease. Indeed. recent clinical studies have employed
adjunctive agents (e.g .. dexamethasone) in an attempt to re-
duce mortality and alleviate neurological sequelae [1-4].
These studies and the resulting recommendations regarding
the use of adjunctive dexamethasone have recently been re-
viewed [5.6].
In line with the current emphasis on the pathogenesis and
pathophysiology ofbacterial meningitis. two workshops were
held in California in the 1980s [7]. Recognizing that many
advances have been made in this field in the several years
since those meetings. the Department of Neurology at the
University of Munich organized a similar workshop, which
was held in Eibsce. Germanv. on 25 and 26 June 1993. As IS
evident from its title-"Bacterial Meningitis: Mechanisms of
Brain Injury"-the workshop focused on the pathophysiol-
ogy of brain dysfunction during bacterial meningitis. Also
considered. however, were many other areas of investigation.
including pathogenesis. diagnosis. and therapy, Ihe work-
shop brought together approximately 50 scientists working
in diverse fields (including neurology. infectious diseases. pe-
diatrics, neuropathology. microbiology. immunology. molec-
ular biology. and free-radical chemistry) in a setting favor-
able to the exchange of ideas. This article summarizes the
presentations delivered at the workshop and. 111 light of these
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presentations, suggests some fruitful areas for future investi-
gation.
Clinical Aspects of Brain Injury in Bacterial Meningitis
Karen Roos (Indianapolis, Indiana, USA) presented a
broad overview of the clinical aspects ofbacterial meningitis,
especially its complications. Roos reviewed a retrospective
study documenting various complications of community-ac-
quired meningitis in adults [8]. On admission or within the
first 24 hours thereafter, 29% of patients had focal seizures or
focal neurological findings. Previous studies had shown that
seizures occurring during acute meningitis correlate with
subsequent (late) seizures and with neurological sequelae.
Sixty percent of the seizures associated with the acute disease
occur in the first 2 days of hospitalization, and 20%-40% of
all patients with bacterial meningitis develop seizures at
some point. Focal and generalized seizures as well as unpro-
voked seizures are documented in -- 13%of survivors within
5 years after the acute illness. The pathophysiological picture
of seizures in meningitis is complex and includes fever, hy-
ponatremia (due to the inappropriate secretion of antidi-
uretic hormone), cerebrovascular disease (focal ischemia
and/or infarction), intracranial mass lesions (brain abscess,
subdural effusion, or subdural empyema), and antibiotic tox-
icity [9].
Roos's presentation and the subsequent discussion under-
scored some practical issues in the management of seizures.
One recommendation is to treat all patients who have pneu-
mococcal meningitis with phenytoin at the time of presenta-
tion (loading dose, 20 mg/kg iv) in light of the high incidence
of seizure activity in this group. Such treatment may prevent
the development of status epilepticus but apparently does
not reduce the incidence of focal seizures. The impact of this
practice on ultimate mortality is unknown. Roos also dis-
cussed the pathophysiology and management of increased
intracranial pressure (ICP). The development of increasing
ICP is suggested by findings on clinical examination. A pa-
tient who is awake and alert does not need an ICP-monitor-
ing device; however, as the level of consciousness deterio-
rates from confusion to stupor and then to coma, such a
device should be used. Components in the management of
increased ICP include (1) hyperventilation (to lower arterial
carbon dioxide pressure [Paco-] to 25 mm Hg), (2) elevation
of the head of the bed to 30 degrees, and (3) induction of
coma with use of pentobarbital (loading dose, 5-10 mg/kg,
with the serum level titrated to achieve a burst-suppression
pattern on electroencephalography). No consensus was
reached by the participants on the use of mannitol in the
routine management of bacterial meningitis. Roos recom-
mended the use of dexamethasone (0.15 mg/kg iv) every 6
hours for the first 4 days of antimicrobial therapy, with the
first dose of dexamethasone administered 20 minutes before
the first dose of antibiotic.
Figure 1. Right-carotid angiography (lateral view from a com-
mon internal carotid artery injection) in a 66-year-old patient with
pneumococcal meningitis. Angiographydisclosed marked narrow-
ing in the supraclinoid portion of the right internal carotid artery
(arrow); this change resembledvasospasmassociatedwithsubarach-
noid hemorrhage secondary to aneurysm rupture.
The results ofa prospective study of86 adult patients with
bacterial meningitis were reviewed by Hans-Walter Pfister
(Munich, Germany) [10]. This was the first published pro-
spective study of neurological complications in such pa-
tients. All patients with a Glasgow coma scale score of <8,
with focal deficits, or with no improvement after 3 days of
antibiotic therapy underwent computed tomography (CT). If
the coma score was still <8 after 3 more days of therapy,
patients underwent angiography as well. Of the 86 patients,
35 suffered intracranial complications, including angiograph-
ically documented cerebrovascular involvement in 13 cases,
cerebral edema in 12, hydrocephalus in 10, and cerebral her-
niation in 7. Some patients had obvious narrowing of the
major arteries at the base of the brain-a finding that is sug-
gestive of vasospasm (figure 1) and is analogous to the situa-
tion observed in some cases of subarachnoid hemorrhage.
Cerebrovascular complications were associated with a very
poor prognosis: 6 patients died, 5 developed neurological
sequelae, and only 2 recovered completely. Hydrocephalus
was documented as early as the first day after admission and
up to several weeks after the initiation of therapy. The sys-
temic complications during the acute illness consisted
mainly of septic shock, disseminated intravascular coagula-
tion, and the adult respiratory distress syndrome.
Frank Erbguth (Erlangen, Germany) stressed that patients
with bacterial meningitis may have focal signs and symptoms
or seizures that mask the underlying diffuse process. The
differential diagnosis includes arterial lesions (involving
small, medium, and/or major arterial branches), venous oc-
clusion, and cerebritis. Hypodense lesions evident on CT
may not appear for several days after admission. Erbguth
reminded participants that patients may develop a stroke-
like syndrome in the absence of fever.
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Volker Schuchardt (Heidelberg, Germany) presented the
results of a long-term follow-up study of 73 patients with
bacterial meningitis, including 10 patients with tuberculous
meningitis. A poor prognosis was associated with the ex-
tremes of age, severe underlying diseases, a pneumococcal or
tuberculous etiology, the presence ofcerebritis or abscess (as
detected by CT), and coma. This series from Heidelberg was
consistent with other large series ofadult patients with bacte-
rial meningitis in terms of the incidence of sequelae and/or
complications [1 L 12].
Benjamin C. P. Lee (S1. Louis, Missouri, USA) discussed
the intriguing use of magnetic resonance imaging (MRI) and
magnetic resonance (MR) angiography in the diagnosis of
complications of bacterial meningitis. MRI and MR angiog-
raphy are very sensitive for the detection of venous and arte-
rial changes, including infarction, venous sinus thrombosis,
and arterial stenosis, occlusion, and spasm. MR angiogra-
phy, which does not require contrast enhancement, is clearly
superior to CT for the diagnosis of thrombosis of cavernous
and other major dural sinuses and may be a suitable alterna-
tive to conventional angiography. However, MR angiogra-
phy is dependent on the rate of blood flow and cannot differ-
entiate slow flow from total occlusion. Because it yields
images of the internal auditory canal and the cochlear aque-
duct, MRI may prove useful for differentiating the routes of
infection leading to hearing impairment during bacterial
meningitis.
Finally, Hilmar Prange (Gottingcn, Germany) discussed
the CSF concentration of the elastase-o-J proteinase inhibi-
tor as a marker for discriminating bacterial from viral menin-
gitis. He described studies in which the concentration of this
inhibitor was elevated in CSF from 20 patients with bacterial
meningitis and from a few patients with tuberculous meningi-
tis but not in CSF from patients with viral meningitis or other
neurological diseases, including Lyme neuroborreliosis.
Concentrations in patients with bacterial meningitis and
those in patients with viral meningitis did not overlap. Thus,
measurement of this inhibitor may be useful in differentiat-
ing these diseases. Follow-up evaluation of the patients sug-
gested that the CSF concentration of this inhibitor correlates
with CSF neutrophil concentration.
Morphological Alterations During Bacterial Meningitis
Philip R. Dodge (S1. Louis) began the session with a com-
plete review of the route of infection, pathogenesis, pathol-
ogy, and complications of bacterial meningitis. The focus of
the presentation was that-as cited in several reviews and in
an editorial published several years ago by Morton N. Swartz
in the New England Journal of Medicine-"meningitis in-
volves more than just the meninges" [13, 14).
Cerebrovascular involvement is a frequent complication
of bacterial meningitis [15]. In addition to infiltration of the
vessel wall by inflammatory cells, an active vascular re-
sponse to the infection-e-i.e .. vdsospasm-may occur. As a
consequence of vascular involvement. brain infarction may
take place [16]: in rare cases. spinal cord infarction has been
reported. Subdural effusion is not a common problem in the
adult population hut in some studies has occurred in 3mr-
50%of children with bacterial meningitis. Onlv >- Icr of chil-
dren with subdural fluid collections develop subdural em-
pyema. which usually requires surgical intervention. The
cerebral ventricles frequently become enlarged. However. in
only I%-2% of patients is hydrocephalus severe enough to
require surgical treatment. The most common neurological
complication in children is some degree of sensorineural
hearing impairment. A prospective study of acute bacterial
meningitis in children showed that "'-' I0% of patients had
persistent bilateral or unilateral sensorineural hearing loss
[17]. This impairment is most likely secondary to cochlear
dysfunction due to the presence of viable bacteria in the co-
chlea and cochlear aqueduct. Infarction due to local blood-
vessel invasion may also be an important factor.
The neuropathology of experimental pneumococcal men-
ingitis in an adult rat model was discussed by Martin G.
Tauber (San Francisco). With his colleagues. Tauber exam-
ined neuropathological features between 24 hours and )
days after infection. Early changes appeared to be confined
to the subarachnoid space (SAS); later in the infection. granu-
locytic infiltrates were found along cortical vessels in the
Virchow-Robin spaces. Some of these infiltrates appeared to
be evolving into frank abscesses. Although studies of the rat
model documented extensive leukocytic infiltration along
blood vessels into the cortical parenchyma, they revealed
little neuronal damage adjacent to the infiltrates. The extent
of SAS inflammation and vascular involvement appeared to
increase with the size of the bacterial inoculum in this model.
The background neuropil was altered focally. and few pyk-
notic neurons were seen. Neuronal changes were detected in
only a minority of animals. Some changes were found in the
hippocampus. The paucity of findings indicative of neuronal
injury and the focal nature of the changes that were detected
were prominent points in Tauber's presentation. During the
discussion, the lack of induction of heat-shock protein 72
was mentioned [18]: in light of this observation. it is doubtful
that all of the changes documented were secondary to hyp-
oxia alone. Furthermore. since there was virtually no change
in the CSF glucose concentration, the changes were not due
solely to hypoglycemia and/or hypoglycorrhachia. The
correlation of neuronal changes with the bacterial concentra-
tion in CSF and with the CSF leukocyte response. the im-
proved resolution with electron microscopy. and the use of
other bacterial pathogens (e.g., gram-negative organisms) for
challenge were cited as promising areas for future investiga-
tion.
The toxic effects of pneumococci on cultured rat astro-
cytes and cerebral endothelial cells were reviewed by Andrea
Bernatowicz (Munich). Pneumococcal cytotoxicity was as-
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Figure 2. Cytotoxicity of live pneumococci for cultured rat cerebral endothelial cells and astrocytes. A: Confluent monolayer of primary
rat endothelial cells cultured for 5 days. B: Endothelial cells 6 hours after exposure to live pneumococci ( 107 cfu/ml.), The monolayer is
destroyed. Lysed cells can be identified. Some islands of endothelial cells are still recognizable. C: Primary rat astrocytes cultured for 14
days. D: Astrocytes 48 hours after exposure to live pneumococci (10 7 cfu/rnl.). The polynuclear symplasms are disconnected, and the cell
contours can no longer be recognized.
sessed by morphological studies and measurements oflactate
dehydrogenase (LDH) activity. Primary cultures of unpas-
saged astrocytes and of endothelial cells up to the first
passage were used. Damage to astrocytes was documented
morphologically after exposure to heat-inactivated pneumo-
cocci. LDH activity was apparent as early as 0.5 hour after
exposure of astrocytes to pneumococci. In contrast, neither
morphological alterations nor LDH activity was apparent in
endothelial cells after exposure to heat-inactivated pneumo-
cocci for 0.5 hour to 192 hours. However, morphological
changes in endothelial cells were seen after exposure to live
pneumococci (figure 2). The pneumococcal strain used in
such studies appears to be critical. The investigators used the
S3 strain, which is noninflammatory in a rabbit model when
heat inactivated, presumably because the capsule prevents
recognition of the proinflammatory cell wall. It was sug-
gested that the heat-inactivated, unencapsulated R6 strain
be used in this assay.
Finally, Pedro M. Faustmann (Essen, Germany) pre-
sented some preliminary data documenting the early appear-
ance of mononuclear phagocytes in the SAS during acute
meningitis. Specifically, these cells appeared in the SAS of
both rabbits and rats within I hour of the intracerebral injec-
tion of complement component C5a (100 J-Lg in rabbits and
10 J-Lg in rats). Electron microscopy revealed interaction of
the macrophages with polymorphonuclear leukocytes
(PMN s) via pseudopodia in the cisterns of the SAS. In addi-
tion, an interaction of macrophages and astroglia was de-
tected. Studies with monoclonal antibodies specific for
mononuclear cells and/or for cells of macrophage lineage
showed an increased number of ED2-positive cells within
the SAS in the first hour after stimulation in rats. This very
early phase ofexperimental meningitis was the focus ofsome
discussion, which centered in particular on the specificity of
the antibody (ED2) and the source of the mononuclear cells.
Mononuclear cells or macrophages may be mobilized from
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sites within the CNS or may enter the SAS from an intravas-
cular source. These possibilities require further experimental
assessment.
How Microorganisms Challenge the Host in Bacterial
Meningitis
Alexander Tomasz (New York, New York, USA) began
his review by reminding workshop participants of the rapid
spread and increasing incidence of pneumococci resistant to
multiple antibiotics. He cited a case in the United States in
which ceftriaxone treatment of pneumococcal meningitis
failed. The isolate was resistant to penicillin, third-genera-
tion cephalosporins, irnipenern, erythromycin, chloram-
phenicol, tetracycline, and trimethoprim-sulfamethoxazole.
Ultimately, vancomycin had to be used in this instance.
There are ,...., 500,000 cases of pneumococcal pneumonia
and 5,000 cases of meningitis annually in the United States,
and the fatality rate for meningitis is still around 25%-30%. A
recent report from South Africa described pneumococcal
meningitis in children; mortality due to penicillin-resistant
pneumococci was nearly 50% higher than that due to penicil-
lin-susceptible strains [19]. The high incidence of resistant
pneumococcal strains in several countries and the need for
bactericidal activity to control pneumococcal meningitis
constitute a major challenge for the designers of new antimi-
crobial agen ts.
Experiments in a rabbit model indicate that CSF offers a
poor environment for the multiplication of at least some
pneumococcal strains. In some instances a net increase in
bacterial titer was preceded by lag times as long as 20-30
hours after the intracerebral inoculation of an inoculum of
103-104 cfu. Once bacterial growth commences, the time of
onset ofCSF leukocytosis is a remarkably sensitive indicator
of the bacterial concentration. In studies with several capsu-
lar type 2, type 3, and type 19 strains of pneumococci, the
number of PMNs in the CSF began to rise sharply as the
bacterial concentration reached a threshold range (a few
times 106 cfu).
Whether or not iv injection ofa bolus of ampicillin causes
an inflammatory overload (known as the antibiotic-induced
inflammatory burst) also depends on and is very sensitive to
the concentration of bacteria in the CSF at the time of the
injection. Ampicillin had no impact on the course of rapid
pleocytosis when the bacterial concentration was already
above the threshold range. The antibiotic's injection shortly
before this threshold concentration was reached resulted in
the inflammatory burst, while its injection several hours ear-
lier actually postponed the onset of inflammation.
The nature of the inflammatory agent(s) released spon ta-
neously at the inflammatory threshold bacterial concentra-
tion or during treatment with ampicillin is not clear. The
ultimate wall-degradation products of pneumococcal autoly-
tic amidase (the enzyme responsible for the disintegration of
pneumococci during ampicillin-induced lysis) have only
poor or moderate inflammatory activity. On the other hand.
the in vivo triggering of this enzyme shortly after treatmen t
of the bacteria with ampicillin causes a release into the me-
dium of highly polymerized cell-wall structures containing
an intact network of peptidoglycan and teichoic acid in a
soluble form [20]. The specific inflammatory activity of this
macromolecule remains to be tested. An additional intracel-
lular inflammatory agent that does not behave like cell walls
has been identified.
Biochemical studies on the specific inflammatory activity
of well-defined cell-wall fractions from pneumococci and
staphylococci have continued. Structural variants of staphy-
lococcal and pneumococcal muropeptides [21] differ greatly
in inflammatory potential. For instance, oligomeric rnuro-
peptides from the staphylococcal peptidoglycan exhibit
much less inflammatory activity than monomeric subcom-
ponents. Whole cell walls from a penicillin-susceptible
pneumococcal strain and its penicillin-resistant transfer-
mants show different degrees of inflammatory activity, with
the resistant organism's wall causing more rapid inflamma-
tion. This difference is reproduced when muropeptides of
< I ,000 daltons from the two bacteria are compared. These
observations suggest the existence of one or more muropep-
tide receptors on a host cell in the CSF space
Introduction of cell-wall components or live pneumococci
into the cisterna magna triggers an enormous number ofmo-
lecular and pathophysiological events. Collaborative experi-
ments involving Tornaszs and Pfister's groups have identi-
fied one of the early events as an increase in regional cerebral
blood flow, which is followed by an increase in ICP and
pleocytosis. Studies with combinations ofwell-defined bacte-
rial inflammatory components and a variety of anti-inflam-
matory agents (e.g., dexamethasone, superoxide dismutase.
transforming growth factor (3. antibody to ('[) Ig. and cy-
clooxygcnase inhibitors) may enable us to organize these
events into a definitive inflammatory pathway.
Arnold L. Smith (Seattle. Washington. LfSA) next dis-
cussed the mechanisms of nasopharyngeal colonization by
Hib. Smith reviewed the results obtained in the infant maca-
que model of Hib meningitis [22]. The first histopathologic
lesion in the eNS in this model is choroid plexitis. This find-
ing suggests that Hib enters the eNS through the choroid
plexus. As in the rabbit model of pneumococcal meningitis.
no SAS inflammation develops until bacterial concentra-
tions in CSF reach ,...., 10° cfu/rnl.. The use of the primate
model is appropriate since Hib is specific for adhesion to
primate epithelium. Smith reviewed the role of fimbriae in
this adhesion. The expression of fimbriae may be switched
on or offaccording to the conditions in which Hib is growing
(for example, on Hel.a cells or in broth). In cell lines that
mimic the nasopharyngeal epithelium, the bacteria can
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"sense where it is," and fimbrial expression may be switched
on. Furthermore, Hib is capable ofaccurately regulating fim-
brial phase variation in vivo. For example, a-fimbriae are
expressed to enhance binding to the anterior nasopharynx
and IJ-fimbriae to facilitate binding to posterior ciliated naso-
pharyngeal cells. Smith's presentation and the discussion
that followed underscored the need for appropriate in vitro
and in vivo systems in which to evaluate the pathogenesis
and pathophysiology of meningeal pathogens, many of
which are adapted only to primates. In vivo models are criti-
cal for the delineation of complex pathophysiological and
microbiological events. The differences between models may
be subtle, and the interpretation of results obtained in rodent
models may be problematic in some respects.
In the next presentation, Barbara Spellerberg (New York)
discussed preliminary results of studies of the isolation of a
receptor for pneumococci on human brain endothelial cells.
Previous experiments had suggested that the pneumococcal
cell wall plays a role in the attachment ofStreptococcus pneu-
nioniae to human umbilical-vein endothelial cells [23]. In
the studies described by Spellerberg, brain endothelial-cell
lysates were probed by western blots with antibodies specific
for the pneumococcal cell wall, and one band was detected.
Brain endothelial cells were then used to develop a cDNA
library with X-GT II phage and expression in Escherichia
coli. A plaque assay with 3sS-labeled pneumococci was used
to identify putative receptors for the pneumococcal cell wall
on brain endothelial cells. A I 16-kD fusion protein of two
clones was identified as a potential receptor. The discussion
focused on the specificity of those findings. The specificity
of the receptor for brain endothelial cells and for
organisms other than pneumococci is unknown. No direct
evidence that the receptor is surface-expressed on endothe-
lium was presented. These exciting preliminary data sug-
gested a variety of areas for productive investigation in the
future.
A second presentation by Martin G. Tauber focused on
the question: Are bacterial products neurotoxic? Primary
neuronal cultures from embryonic rat brain consist of 90%-
95% pure neurons, with some contamination by astrocytes
and glial cells. For standard assays of neurotoxicity, primary
neurons are grown in culture for ,..., 12 days and are then
exposed to bacteria andjor bacterial products for 2 days.
Tauber presented evidence that primary neurons are less
sensitive to heat-killed pneumococci (R6 strain) than are
U373 astrocytes in tissue culture. Similarly, primary neurons
are less sensitive to pneumococcal cell-wall components
than are U373 cells, which are destroyed in a dose-depen-
dent manner. No change in toxicity in neurons was noted
after exposure to lipoteichoic acid or lipopolysaccharide
(LPS) from Neisseria nieningitidis at concentrations up to 25
JLgjmL. U373 cells also exhibited minimal evidence of toxic-
ity in the MTT assay after exposure to LPS. The striking
resistance of these neuronal cells to various bacterial prod-
ucts was the subject of further discussion.
Finally, Hans Lassmann (Vienna, Austria) described ex-
periments in a rat model of experimental autoimmune en-
cephalomyelitis (EAE) [24, 25] combining immunocyto-
chemical techniques, ultrastructural studies, and in situ nick
translation. Lassmann and co-workers found that up to 49%
of T lymphocytes in EAE lesions showed signs of apoptosis
(programmed cell death) when recovered during disease.
Thus apoptosis ofT lymphocytes is one possible mechanism
for the elimination of these cells from inflammatory brain
lesions. These intriguing results mayor may not be relevant
to bacterial meningitis.
Soluble Inflammatory Mediators
Various aspects of the role ofcytokines and soluble media-
tors in the development ofbrain injury during bacterial men-
ingitis were considered. Bernhard Moser (Berne, Switzer-
land) reviewed the functional and molecular characteristics
of interleukin 8 (IL-8), related cyrokines, and their receptors.
IL-8 was discovered about 6 years ago to be a chemotactic
cytokine in vitro. Injection of IL-8 into the skin of rats in-
duced a rather pronounced local inflammatory response-
consisting mainly of PMNs-within 4 hours after challenge.
The inflammatory potency of IL-8 after intradermal injec-
tion was confirmed by studies of rabbits and humans. IL-8,
formerly referred to as neutrophil-activating peptide I (NAP-
1), belongs to the family of chemokines (chemotactic cyto-
kines: for a review, see [26]). On the basis of the arrangement
of the first two cysteines, the chemokines are divided into
two subfamilies. In the CXC chernokines, the first two cys-
teines (Cs) are separated by one amino acid (X); this group
includes IL-8, the GRO (growth-related gene) peptides, and
NAP-2. In the CC chernokines, the two first cysteines are
adjacent. The most prominent members of this group are
monocyte-chemotactic proteins I, 2, and 3 and macrophage-
inflammatory proteins I (Y and I,B. The CXC chemokines ap-
pear to be highly selective for polymorphonuclear phago-
cytes, whereas the CC chemokines specifically activate
mononuclear cells, including monocytes, eosinophils, baso-
phils, and lymphocytes.
IL-8 is produced by various leukocytes and by a large num-
ber of tissue cells upon stimulation with LPS or the proin-
flammatory cytokines IL-l and tumor necrosis factor (TNF).
IL-8, which is strongly chemotactic for PMNs, causes modifi-
cations in the shape of'neutrophils, release ofenzymes, stimu-
lation of the respiratory burst, and upregulation of IJ-inte-
grins CD-II JCD-18. IL-8 binds to at least two different
PMN receptors, p44 and p70. The first receptor is more spe-
cific for IL-8 than for related cytokines, while the latter has a
similar affinity for IL-8, GRO-a, and NAP-2. The two IL-8
receptors have a seven-transmembrane domain architecture
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typical of G protein-coupled receptors. The major form of
IL-8 isolated from the medium ofcultures of activated blood
monocytes consists of 72 amino acids and has been identi-
fied as a dimer by nuclear MR studies and X-ray diffraction
of IL-8 crystals. The C terminus of the molecule is not in-
volved directly in receptor binding, but deletions at the N
terminus reduce the activity of IL-8. The integrity of each of
the three residues that precede the first cysteine (Glut-Leu >
Arg6; ELR) is critical for receptor binding and neutrophil-sti-
mulating activity. Recently, a series of analogues ofIL-8 (4-
72)-the truncated form of IL-8 with the N-terminal
sequence ELRC-were synthesized as potential IL-8 antago-
nists [27]. The discussion of this elegant work focused on the
potential role of IL-8 in CNS disease. LPS induces the ex-
pression of IL-8, but the role of this cytokine in CNS infec-
tion is unknown. The time course of IL-8 expression after
LPS stimulation requires further study. Whether or not IL-8
receptors exist on endothelial cells also needs to be deter-
mined.
The potential role of IL-8 in experimental meningitis was
investigated by Rachel Dumont and Terry O'Reilly (Basel,
Switzerland). The authors noted that IL-8 was present in the
CSF of patients with bacterial meningitis at concentrations
ranging from 0.3 to 24 ng/mL. IL-8 is capable of enhancing
PMN migration across an endothelial-cell monolayer and
therefore may playa role in SAS inflammation. These re-
searchers injected IL-8 and related substances (human re-
combinant IL-8, rabbit IL-8, human recombinant GRO, and
human recombinant NAP-2) intracisternally into rabbits.
The results, somewhat surprisingly, documented a lack of
CSF pleocytosis during the 7 hours after challenge with all
four molecules. However, the rabbits did respond to intracis-
ternal challenge with LPS injected 7 hours after IL-8. The
discussion of this presentation emphasized future experi-
ments on topics such as the injection oflL-8 along with other
cytokines, the injection of monoclonal antibodies to IL-8
along with an LPS challenge, and the potential influence of
IL-8 on blood-brain barrier disruption.
The role of soluble inflammatory mediators in the patho-
physiology of bacterial meningitis was reviewed by Karl Frei
(Zurich, Switzerland). In collaboration with Adriano Fon-
tana, Frei asked whether cytokines produced intrathecally in
the CNS during experimental infection were involved in the
elimination of microbes from the CNS. In a mouse model of
Listeria monocytogenes meningitis, these investigators docu-
mented that TNF and IL-6 were present in the CSF at 4
hours and that concentrations peaked at '""-'24 hours after
intracerebral inoculation of L. monocytogenes. In contrast,
interferon')' (IFN-')') was not detectable until 24 hours after
challenge. Perhaps the most significant finding was that IL-
10 was also produced late (up to 72 hours) in the course of
listeriosis in mice [28]. The authors used an in vitro system of
murine macrophages (J77A-I cells) on coverslips to investi-
gate the effect of pretreatment with various cytokines on Iis-
terial infection in vitro. No increase in listericidal activity
was apparent after pretreatment with TNF or IL-6. However,
a marked increase in the listericidal activity of J 774A-1 cells
was evident after preexposure to IFN-')' (i.e., activated macro-
phages) and this increase was dependent on the production
of nitric oxide. An interesting finding was that IL-IO im-
paired the listericidal activity of macrophages-an effect du-
plicated when macrophages were exposed to CSF drawn
from mice 48 hours after infection. This effect was reversed
by preexposure to a monoclonal antibody to IL-I 0, which
inhibits nitric oxide synthase. Although IFN-')' and IL-IO
may not playa similar role in meningitis because of the pres-
ence of extracellular bacteria, the potential role of cytokine
modulation of the late events in infection and the complex
interplay of the various cytokines are topics of interest. IL-I 0
is produced mainly by TH2 cells, including monocytes and
macrophages. During the discussion period, Frei presented
data documenting elevated concentrations of IL-I 0 in 959c
of CSF samples from children with bacterial meningitis but
in only 3% of samples from children with viral meningitis.
IL-IO concentrations ranged from '""-' 100 to well over 20,000
pg/ml.. The potential role oflL-1 0 in the diagnosis ofmenin-
gitis and its potential anticytokine activity late in the disease
clearly require further investigation.
Jay H. Tureen (San Francisco) discussed the effects of
TNF on cerebral blood flow and metabolism. With his asso-
ciates, Tureen challenged rabbits intracisternally with type
III pneumococci at two concentrations (5 X 106 cfu and 5x
104 cfu) and measured cerebral blood flow (radiolabeled mi-
crosphere technique), rate of cerebral oxygen metabolism.
CSF lactate level, CSF TNF level (L929 cytotoxicity assay),
and CSF bacterial titers 16 hours and 20 hours later. Cef-
triaxone therapy was initiated 16 hours after challenge. In-
creased bacterial concentrations in CSF correlated with in-
creased concentrations of lactate and TNF. CSF lactate
concentrations were further increased after treatment with
ceftriaxone, which also elicited a burst ofTNF activity. Per-
haps most important. TNF concer.trations in ('SF correlated
inversely with cerebral blood flow and cerebral oxygen up-
take. These findings may reflect the increased incidence of
neurological sequelae among patients with high ('SF bacte-
rial densities associated with a shift to anaerobic metabolism.
In discussing this presentation, participants attempted to de-
fine the primary event in these pathophysiologic alterations.
It was suggested that the primary event was a decrease in
brain oxygen demand coupled with a reduction in cerebral
blood flow. The driving force is clearly a critical variable.
Studies to measure critical variables after challenge with
TNF and/or monoclonal antibody to TNF are planned.
The effect of inflammatory products on primary neurons
in tissue culture was discussed by Martin G. Tauber (San
Francisco). Previous experiments had suggested that the mu-
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rine neuronal cell line HN 33.1 was sensitive to various cyto-
kines, in particular TNF [29]. These studies indicated that
the cytotoxicity in CSF from animals with bacterial meningi-
tis was attributable to TNF since soluble TNF receptors
blocked virtually all of this activity except that observed late
after challenge with either live pneumococci or pneumococ-
cal cell wall. Twelve-day-old primary neuronal cultures were
exposed over 2 days to various cytokines, and cytotoxicity
was measured with the MTT (3-[ 4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide) assay. Although cytotoxic-
ity was observed after exposure to CSF samples from animals
with pneumococcal meningitis diluted in culture medium to
20%-30% (vol/vol), the cytokines examined (IL-l and TNF)
produced cytotoxicity in primary neurons only at concentra-
tions in the micromolar range. Furthermore, synergistic cyto-
toxicity was not evident when submaximal concentrations of
IL-l and TNF were used together. IL-l was marginally more
active than TNF in the induction ofcytotoxicity in this assay.
The discussion of this presentation focused on questions re-
garding the relative susceptibilities of embryonic neurons
and neurons of older animals, the change of embryonic neu-
rons with age in culture, the response of embryonic neurons
to N-methyl-o-aspartate antagonists, and other issues. Pri-
mary neurons are remarkably resistant to cytokines in this
system.
Leukocyte-Endothelial Cell Interactions
The critical role ofleukocyte-endothelial cell interactions
in tissue injury-and potentially in bacterial meningitis-
was addressed in several presentations. The broad subject of
these interactions in tissue injury was reviewed by Hans-An-
ton Lehr (Munich). The crucial role of leukocyte-endothe-
lial cell interactions in host defense is underscored by the
development of recurrent bacterial infections in patients
with leukocyte adhesion deficiency. Without the adhesion of
leukocytes, there is no inflammatory response to facilitate
the elimination of an invading microorganism. However,
there is potentially harmful leukocyte activity. Leukocyte-
endothelial cell interactions may cause a local endothelial
lesion, and chemotactic mediators, including leukotrienes,
complement, reactive oxygen species, and platelet-activating
factor, may subsequently be released from the endothelium.
The liberation of these mediators leads to further recruit-
ment of leukocytes at the site of endothelial-cell damage.
Attracted activated leukocytes may release cytotoxic prod-
ucts, such as reactive oxygen species, reactive nitrogen inter-
mediates, and proteolytic enzymes, that may augment tissue
damage, with subsequent edema formation. This leukocyte-
induced tissue damage plays a role in a variety of disease
processes, such as ischemia-reperfusion [30], atherogenesis
[31], and bacterial meningitis [32, 33].
Ruggero Pardi (Milan, Italy) discussed the molecular
mechanisms underlying leukocyte-endothelial cell interac-
tions. Aspects ofadhesion, including the bidirectional mecha-
nism of receptor density, the ability to diffuse within mem-
branes, and ligand affinity, are the focus of Pardi's
experiments. Leukocyte-endothelial cell interactions are
mediated by cell-surface adhesion receptors and their
counter-receptors on leukocytes and endothelial cells, which
include members of the integrin and selectin families and the
immunoglobulin superfamily. Pardi reviewed the interac-
tions of leukocytic integrins (integral membrane proteins)
with intercellular adhesion molecules (ICAM) and with en-
dothelial integrins; these interactions are of low affinity in
the millimolar range. Conversely, selectin-carbohydrate pro-
tein interactions are of high affinity in the nanomolar range,
but the association-dissociation of these events is very rapid.
L-selectin interacts with a vascular addressin rich in carbohy-
drates and important in the homing of lymphocytes. Pardi
suggested that leukocytes are never adhesive under resting
conditions; thus leukocyte adhesiveness requires triggering
by external stimuli. Increasing evidence supports the involve-
ment of members of the selectin family (namely, L-selectin
expressed by leukocytes and P-selectin on endothelial cells)
in the initial rolling of leukocytes along the endothelium.
This process precedes firm adhesion and transmigration [34].
The earliest detectable intracellular event associated with ad-
hesion-membrane phosphoinositide breakdown followed
by the production of inositol-l ,4,5-triphosphate and diacyl-
glycerol-results in calcium-dependent protein kinase C ac-
tivation and a transient Ca2+ increase [34]. In Pardi's pro-
posed model, leukocyte adhesion is dependent on activation
and mediated by lymphocyte function-associated antigen I.
The discussion of this presentation centered on potential sec-
ond messengers relevant to leukocyte-endothelial cell inter-
actions. Pardi reported that many leukocyte adhesion mole-
cules are signal transducers. For example, after the adhesion
of neutrophils, the dominant neutrophil integrin (CD II b/
CD 18) triggers the generation of oscillating intracellular cal-
cium transients, which are associated with exocytosis and
phagosome-lysosome activity.
The relevance of these complex interactions ofleukocytes
and endothelial cells for bacterial meningitis was the subject
of the next presentation, which was delivered by Eva Rozd-
zinski (N ew York). She described a hypothetical scheme in
which the entry of bacteria into the CSF is followed by the
release of cell-wall or other inflammatory stimulants whose
enhancement of leukocyte adhesion to endothelial cells
(with modulation by cytokines) leads to alterations in blood-
brain barrier permeability. Rozdzinski also reviewed selec-
tin-mediated leukocyte-endothelial cell rolling mechanisms
and subsequent integrin-mediated adhesion events. The
influence of these two sequential mechanisms on the micro-
circulation of the CNS is poorly understood. Rozdzinski re-
viewed experiments with a monoclonal antibody to adhe-
sion-promoting receptors on leukocytes (IB4) in a rabbit
model of meningitis [32]. Treatment of rabbits with IB4 (1
CID 1994;19 (September) Brain Injury in Bacterial Meningitis 471
mg/kg) reduced CSF pleocytosis after challenge with live bac-
teria (meningococci, pneumococci, or Hib), pneumococcal
cell wall, or Hib LPS. IB4 did not influence the incidence of
bacteremia in this model but did improve rates of survival.
Evidence suggests that IB4 reduced leukocyte migration
across an endothelial-cell monolayer in vitro in a dose-de-
pendent manner. In studies of rabbits with pneumococcal
meningitis, Rozdzinski and colleagues administered ampicil-
lin 15 hours after infection and then administered IB4 and
dexamethasone by the iv route. IB4 appeared to be more
effective than dexamethasone in the reduction of CSF pleo-
cytosis. Furthermore, and perhaps somewhat surprisingly,
IB4 appeared to be more effective than the combination of
IB4 and dexamethasone in this model. These results conflict
with data from previous studies of experimental Hib meningi-
tis [33]. Inhibition of leukocyte-endothelial cell interac-
tions, with the reduction of CSF pleocytosis, probably has
both negative and positive consequences in the human host.
This possibility must be studied carefully before relevant
clinical trials are contemplated.
The IB4 study demonstrated that members of the integrin
family are involved in leukocyte-endothelial cell interaction
and in subsequent injury during pneumococcal meningitis.
In a further study, the role of members of the selectin family
in the pathophysiology ofpneumococcal meningitis was stud-
ied. Selectins are C-type lectins that recognize carbohydrates
on leukocytes. These proteins are expressed on injured endo-
thelial cells and promote leukocyte margination. Rozdzinski
presented evidence suggesting that subunits S2 and S3 of
pertussis toxin contain carbohydrate recognition domains
and are thus competitive inhibitors of selectin-mediated leu-
kocyte-endothelial cell interactions [35]. S2 and S3 peptides
inhibited the adherence of human neutrophils to human um-
bilical-vein endothelial cells and induced upregulation of the
integrin CR3 on neutrophils in vitro. Rozdzinski and her
colleagues are searching for peptides that block endothelial-
cell adhesion without upregulation of integrins. In the ani-
mal model, the systemic administration of these peptides I
hour after the injection of heat-killed pneumococci of strain
R6 into the cisterna magna reduced CSF inflammation. The
potential for the use of these agents in the systemic treatment
of meningitis in patients was discussed extensively after this
presentation.
Confocal laser scanning microscopy, a sophisticated new
technique for the imaging of leukocyte-endothelial cell in-
teractions in vivo, was described by Stefan Lorenzi (Mun-
ich). Lorenzi and associates investigated dynamic character-
istics of rhodamine 6G-Iabeled leukocytes in the pial
microcirculation during the first 6 hours after the induction
of pneumococcal meningitis in the rat [36]. Closed cranial
windows were implanted for the examination of the pial ves-
sels in vivo. Through optical sectioning, confocal laser scan-
ning microscopy allows the study of pial vessels through an
intact dura mater. A video depicting leukocyte-endothelial
Figure 3. Leukocyte adherenceto microvascular endotheliumin
a pial venule of an infected rat. A closed cranial window was im-
planted in an anesthetized rat without removal of the dura mater.
and confocal laserscanning microscopy wasusedforin vivo exami-
nationof the cerebral microcirculation. Intravenous rhodamine 6G
selectively stained whitebloodcellsand platelets but not endothe-
lial cells. The numberof rhodamine 6G-Iabeled leukocytes adher-
ing to venularendothelium wasincreased 3 hoursafter intracister-
nal injection of live pneumococci (arrows). Bar = 10 tim.
cell interactions in real time was shown: this video docu-
mented the augmented adhesion of leukocytes to the cere-
bral microvasculature as early as I hour after pneumococcal
infection in the rat model. Leukocyte adherence to microvas-
cular endothelium occurred in pial venules but not in arteri-
oles (figure 3). Pretreatment of the rats with dexamethasone
decreased leukocyte adhesion and extravasation into the ex-
tracellular space. Administration of the novel 21-aminoster-
oid agent U74389F, a potent inhibitor of lipid peroxidation
[37], also appeared to decrease leukocyte extravasation. The
mechanism of the effect ofU74389F on leukocyte-endothe-
lial cell interactions is unknown.
Molecular Mechanisms of Neuronal Injury
A potpourri of eight presentations examined various puta-
tive mediators of neuronal injury during meningitis-
currently a primary topic of investigation. The production of
nitric oxide. superoxide, and peroxynitrite by activated in-
flammatory cells was reviewed by Joseph Beckman (Bir-
mingham, Alabama. USA). Reactive oxygen species have
been implicated as mediators of brain injury in a variety of
conditions, including cerebral ischernia/reperfusion injury.
experimental fluid/percussion brain injury. cold-induced
brain edema. cerebral arteriolar abnormalities after acute ar-
terial hypertension. and bacterial meningitis 138--40]. Super-
oxide radical and hydrogen peroxide may interact via the
iron-catalyzed Habet-Weiss reaction to produce the highly
active hydroxyl radical, which. in turn, may initiate lipid per-
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oxidation and cellular injury. Beckman presented evidence
suggesting that the Haber-Weiss reaction is too slow to dam-
age tissue in vivo. In contrast, the interaction of superoxide
with nitric oxide to form the powerful oxidant peroxynitrite
anion occurs at the very high rate of 6.7 X 109 M-1s- 1and
therefore is ,..., I million times faster than the Haber-Weiss
reaction. Pathological conditions such as inflammation, isch-
emia followed by reperfusion. and sepsis can substantially
upregulate the production of superoxide and nitric oxide in
stimulated macrophages and neutrophils, thereby increasing
peroxynitrite formation. When protonated. peroxynitrite de-
composes to generate highly reactive agents-apparently hy-
droxyl radical and nitrogen dioxide (N02) [41]. At physiolog-
ical pll. peroxynitrite has a half-life of r- I second that allows
it to diffuse to critical cellular targets before decomposing.
Thus, peroxynitrite can diffuse ,..., 10,000 times longer than
the hydroxyl radical. Peroxynitrite interacts with various
metals to form nitro groups on proteins as a marker of its
presence. Superoxide dismutase (SOD), which inactivates
superoxide anion radical. may prevent the formation oftoxic
peroxynitrite from superoxide and nitric oxide [41]. How-
ever, it has been shown that peroxynitrite reacts with SOD to
produce a species with the reactivity ofa toxic nitronium ion
(NOH); as a result, tissue injury is perpetuated [42]. Since
catalase scavenges nitric oxide in addition to hydrogen perox-
ide, in vivo experiments with catalase must be interpreted
with caution.
Beckman presented satisfactory evidence suggesting that
peroxynitrite (as opposed to nitric oxide) is a neuronal toxin
in vivo. The cytotoxic peroxynitrite has been implicated as a
mediator of cerebral ischemic injury [41]. The concentration
of nitric oxide synthase is highest in the brain-i.e., at least
20-fold higher than levels in endothelial cells. Nitric oxide
concentrations of2-4 J.LM in ischemic brain [43] account for
,..., 10%of oxygen consumption by the CNS during ischemia.
These concentrations should be contrasted with nitric oxide
concentrations within macrophages, as opposed to 0.4 J.LM in
endothelial cells and much less than 0.1 J.LM in most other
cell types. Nitric oxide diffuses ,...,45 J.Lm during its in situ
half-life of r- 1 second. In contrast, hydroxyl radicals perfuse
only about a tenth of the diameter ofa protein in situ and are
therefore of doubtful significance during ischemia. Beckman
presented evidence suggesting that nitric oxide itselfdoes not
kill bacteria in vitro, even at I mM. In contrast, all E. coli
cells were killed within 10 seconds by exposure to peroxyni-
trite [44].
Nitric oxide is much more than a vasodilator. It plays im-
portant roles in the control of systemic blood pressure, respi-
ration, digestion, penile erection, platelet aggregation, cere-
bral blood flow, and neuronal synaptic plasticity [42, 45].
There is increasing evidence that nitric oxide or a secondary
oxidant derived from it is also involved in the pathophysiol-
ogy ofbacterial meningitis (see Kadel and Berkowitz below).
Clearly, the production of nitric oxide in situ and its appear-
ance in CSF require additional study. Furthermore, potential
interactions of nitric oxide and various cytokines may be
promising areas of investigation. Nitric oxide was the "mole-
cule of the year" in 1992 [46]; those in attendance at this
presentation were left with the impression that the molecule
of the year in 1994 may be peroxynitrite.
The role of reactive oxygen species, a group of potential
mediators of neuronal and endothelial injury during bacte-
rial meningitis, was reviewed by Hans-Walter Pfister (Mun-
ich), who summarized experiments in a rat model of early
pneumococcal meningitis. Continuous infusion of SOD
(22,000 U[kg· h] iv) prevented the early increase in regional
cerebral blood flow as well as the increase in ICP and brain
water content typical of this early (6-hour) model [47]. Like-
wise, polyethylene glycol-conjugated SOD (PEG-SOD;
10,000 U/kg iv) was effective in preventing increases in ICP
and brain water content in meningitis induced by intracister-
nal injection of pneumococcal cell-wall components [40].
The effect of SOD infusion was more pronounced than that
of catalase infusion (25,000 U/[kg· h] iv) in the same model
[48]. Perhaps more important, SOD reduced ICP and brain
water content when given as late as 3 hours after intracere-
bral inoculation of pneumococci. A role for oxygen radicals
in the pathophysiological alterations that take place during
bacterial meningitis was supported by recent studies by Ber-
kowitz and Traystman [49]. Intravenous PEG-SOD and
PEG-catalase prevented impairment of microvascular auto-
regulation in Hib meningitis in rats. SOD may act by pre-
venting the formation of toxic peroxynitrite from superoxide
anion radical and nitric oxide [41]. Pfister cited results from
studies by McKnight et al. [50] documenting an increase in
pial arteriolar diameter following the topical application of
group B streptococci to the brain surface in rats. Treatment
with iv PEG-SOD (10,000 U/kg) and PEG-catalase (20,000
U/kg) before exposure to group B streptococci prevented va-
sodilation; this result indirectly supports a role for reactive
oxygen species. Nevertheless, as was evident from the discus-
sion of this presentation, the exact site ofoxygen radical gen-
eration during bacterial meningitis is still unknown. Further-
more, in all experiments to date, the Munich group has
employed an early model of bacterial meningitis (within 6
hours of challenge), and the role of reactive oxygen species
in the later stages of the disease remains poorly defined.
Some preliminary results with a new optical method for
the detection of free radicals in vivo were presented by
Ulrich Dirnagl (Munich). Dirnagl and colleagues used a cra-
nial window technique in the rat with lucigenine-enhanced
chemiluminescence to monitor the generation of free radi-
cals in situ [51]. The photon count rate increased after intra-
cisternal inoculation of live pneumococci; this effect was at-
tenuated in the presence ofSOD. The strength of the method
is that it allows for continuous measurement of free-radical
production in situ. Although methodological concerns must
still be addressed, this method is promising and may provide
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further information on the role of reactive oxygen species in
experimental infection.
Indirect evidence for a pathophysiological effect of nitric
oxide during the early phase of pneumococcal meningitis
was presented by Uwe Kadel (Munich). Kodel utilized the
early model ofexperimental pneumococcal meningitis in the
rat [47]. Three hours after intracisternal injection of live
pneumococci. NG-nitro-L-arginine (l-NA), a competitive in-
hibitor ofL-arginine, was given by bolus injection at a dose of
5 or 10 mg/kg, with a subsequent continuous iv infusion of 5
or 10 mg[kg· h). Acting in a dose-dependent manner, l-NA
reversed the increase in regional cerebral blood flow typical
of this model. In addition, this inhibitor prevented the devel-
opment of brain edema and an increase in ICP and reduced
the degree of CSF pleocytosis. However, the higher dose of
l-NA resulted in the death of four of five rats between the
second and third hour of treatment, whereas none of the rats
that were infected and then either left untreated or treated
with the lower dose died. Similar increased mortality rates
were reported by Cobb et al. [52], who administered NG
amino-t-arginine to awake dogs after challenge with endo-
toxin, and by Haberl et al. [53], who administered l-NA
methyl ester to rats with experimental pneumococcal menin-
gitis. Studies investigating the effect of l-NA in uninfected
rats are warranted.
Ivor D. Berkowitz (Baltimore, Maryland, USA) described
experiments suggesting that nitric oxide contributes to pial
arteriolar dilation and impaired autoregulation of cerebral
blood flow during experimental Hib meningitis in rats. Pial
vessels were directly visualized through a closed cranial win-
dow, and Hib was topically applied to the brain surface (at a
concentration of 105 cfu/rnl. of artificial CSF). Autoregula-
tion was assessed as the ability of pial arterioles to dilate in
response to hemorraghic hypotension [54). In infected un-
treated rats, the degree of pial arteriolar dilation documented
was ,....., 150% (with baseline dilation assigned a value of
100%). Pretreatment of rats with 20 mg of l-NA methyl es-
ter/kg prevented pial arteriolar dilation 4 hours later. Auto-
regulation ofcerebral blood flow was preserved in this model
after the administration of l-NA methyl ester. The results
reported are in accordance with previous studies by the Mun-
ich group [53], who reported that the administration of
l-NA methyl ester attenuated the pathophysiological
alterations typical of the early phase of experimental pneu-
mococcal meningitis in the rat. However, these experiments
must be interpreted cautiously since l-NA methyl ester not
only is thought to be a competitive antagonist of nitric oxide
synthase but also has been shown to be a muscarinic receptor
antagonist [55].
H. Niels Diemer (Copenhagen, Denmark) next reviewed
the role of excitatory amino acids in CNS pathology. The
excitotoxic hypothesis of neuronal injury proposes that glu-
tamate or related endogenous excitatory neurotransmitters
become toxic through their interaction with glutamate recep-
tors and that subsequent intracellular events result in neuro-
nal death [56, 57). The glutamate receptors are divided into
groups: the ionotropic N-methyl-D-aspartate (NM DA) re-
ceptors: the non-NMDA. kainate/quisqualate receptors: and
the metabotropic glutamate receptors, which instead of pos-
sessing an intrinsic ion channel exert their effects through
second-messenger systems hy activation of a G protein. The
protective effects of glutamate receptor antagonists suggest
that excitatory amino acids are involved in the pathogenesis
ofcerehral ischemia, profound hypoglycemia, and status cpi-
lepticus. Elevated extracellular concentrations of glutamate
and aspartate in rat hippocampus during transient ischemia
have been documented by microdialysis techniques [58]. Re-
uptake ofamino acids is energy dependent at the synapse via
transporters on a sodium-potassium gradient: the loss of this
gradient during ischemia leads to the accumulation of these
toxic amino acids. The use ofNMDA antagonists, including
MK-80 I and a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid (AMPA) antagonists such as 2,3-dihydroxy-6-ni-
tro-7-sulfamoyl-henzo (f) quinoxaline. to protect ischemic
tissues is a focus of intense investigation. The AMPA recep-
tor is pentameric. Diemer presented evidence showing that
the components of this receptor are encoded on different
chromosomes: these components are designated gluR I
through gluR4. A change in a single amino acid in gluR2
determines whether or not the channel is permeable to cal-
cium. Various mechanisms that may attenuate the NMDA
receptor-mediated current were discussed. For example. the
accumulation of lactate in the ('SF during bacterial meningi-
tis renders the extracellular milieu acidic. and this aciditv
may reduce the potential for damage after meningitis and/or
hypoglycemia-hypoxia. The current status of MK80 I was
raised during the discussion: this compound has not been
introduced into clinical practice because of its psvchomime-
tic properties.
The potential role of excitatory amino acids in the patho-
physiology of bacterial meningitis was reviewed by Martin
G. Tauber (San Francisco). Five papers. puhlished from
1975 to 1982. documen ted elevated concentrations of
amino acids-including 'Y-aminobutyric acid. glutamate.
glycine, and aspartate-in CSF from patients with bacterial
meningitis (cited in [59]). Concentrations of amino acids in
CSF appear to peak I or 2 days after initiation of therapy. No
data are available on amino-acid accumulation in the brain
of patients with bacterial meningitis. Tauber reviewed the
results of measurements of amino acid concentrations in the
CSF and brain ofrahhits with pneumococcal meningitis [59].
Standard CSF analyses were conducted. and microdialysis
techniques were used to document the accumulation ofhoth
lactate and amino acids in brain interstitial fluid. Concentra-
tions of glutamate, aspartate. glycine. taurine. and alanine
increased after 22 hours in ('SF from infected animals: there
was no concomitant increase in the level of asparagine, ser-
ine, or threonine. Glutamate was the only excitatory amino
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acid to appear in increased concentrations in brain intersti-
tial fluid after 22 hours. Levels of alanine also increased sig-
nificantly at this site after 22 hours. As alanine is considered
a marker for anaerobic glycolysis, perhaps it was not surpris-
ing that its concentrations in brain interstitial fluid were
correlated with those of lactate. Tauber also noted an in-
crease in levels of quinolinic acid in CSF and brain during
experimental bacterial meningitis. This substance plays a po-
tential role in the development of encephalopathy in pa-
tients with AIDS, but its role in meningitis is unknown.
Much of the discussion of this presentation was concerned
with the mechanism(s) of excitatory amino-acid accumula-
tion in the brain during meningitis. Alterations in blood-
brain barrier permeability to amino acids, the release of
amino acids from cells within the CNS, a decline in mecha-
nisms of amino-acid clearance from the SAS, and accen-
tuated binding ofamino acids to brain tissue are all possibili-
ties. These issues are difficult to study in vivo with current
techniques.
Adriano Fontana (Zurich) presented intriguing informa-
tion on the potential neurotoxicity of macro phages. Neurons
were isolated from the cerebellum of 7-day-old mice and ex-
posed to macrophages at a ratio of I macrophage to 10 neu-
rons [60, 61]. The neurons were destroyed within 24 hours in
this in vitro system. IL-L TNF, IL-6, and IFN-)'-both
alone and in combination-were not cytotoxic. In cocul-
tures of macrophages and neurons, induced neurotoxicity
was blocked by an NMDA receptor blocker but not by cata-
lase or SOD. This result raised the interesting possibility that
macrophages produce excitatory amino acids that contribute
to neuronal toxicity. Direct evidence was provided that mac-
rophages release glutamate, which can be detoxified by astro-
cytes. Thus, a balance between the amount ofglutamate pro-
duced and the capacity for its detoxification by astrocytes
may be crucial to the development of macrophage-mediated
neurotoxicity. The contribution of excitatory amino acids to
this form of toxicity requires further study.
Cerebral Blood Flow and Metabolism During Bacterial
Meningitis
Jay H. Tureen (San Francisco) reviewed the changes in
cerebral blood flow and metabolism in bacterial meningitis.
A decrease in cerebral blood flow has been observed in pa-
tients with this infection [62-65]. The data on cerebral blood
flow in animals with experimental meningitis are extensive
and sometimes conflicting. As assessed by the radiolabeled
microsphere technique, cerebral blood flow varies somewhat
with time after experimental infection. There is an early hy-
peremic phase during experimental pneumococcal meningi-
tis in the rabbit (a finding similar to those obtained by the
Munich group using Doppler flow techniques in a rat
model), with a decline in blood flow later in infection.
Twenty hours after pneumococcal challenge, total cerebral
blood flow is reduced by --25%. Hippocampal blood flow in
the same animal is reduced to -- 50% of control values.
Whereas autoregulation ofcerebral blood flow is maintained
in normal animals, this ability is generally lost during experi-
mental pneumococcal meningitis [66]. ICP remains stable
despite marked alterations in cerebral blood flow in normal
animals but rises progressively with changes in cerebral
blood flow in animals infected with pneumococci. There-
fore, artificial increases in blood pressure lead to increases in
cerebral blood flow, which in turn lead to increases in ICP in
animals with meningitis. Fluid-restricted rabbits have further
decreases in mean arterial pressures and cerebral blood flow,
with the accumulation of CSF lactate after treatment with
ceftriaxone, whereas these changes do not occur in euvole-
mic rabbits [67]. The implications for the policy of fluid re-
striction, which may be adhered to rigidly during the early
phase of meningitis because ofconcerns about the syndrome
of inappropriate secretion ofan tidiuretic hormone, were not
lost on the participants during the discussion period. Further-
more, cerebral blood flow declines more rapidly after antimi-
crobial therapy. A more rapid reduction in the bacterial titer
in CSF causes a more rapid reduction in cerebral blood flow,
with obvious potential implications for therapy. Tureen also
reviewed microdialysis experiments whose results supported
the concept that at least some CSF lactate is produced locally
in the brain parenchyma [68]. Other possible sources ofCSF
lactate are bacteria and leukocytes. The rate of glucose ex-
traction across the brain does not change over time, whereas
the rate of cerebral oxygen metabolism falls after challenge
with bacteria at high concentrations. Tureen's review raised
much concern over the delicate balance among cerebral per-
fusion pressure, fluid restriction, ICP, and cerebral blood
flow in patients with meningitis. An additional source of
concern is the possibility that a rapid decrease in bacterial
titer as a consequence of rapidly bactericidal therapy may
temporarily decrease cerebral blood flow.
Anthony Slater (London, United Kingdom) discussed ce-
rebrovascular autoregulation during experimental Hib men-
ingitis in rabbits and the role ofleukocytes in this interaction
[69]. In contrast to results obtained with previous models
[66], the rate of cerebral blood flow measured in these rab-
bits with the microsphere technique was increased 18 hours
after intracerebral Hib challenge. Pretreatment of the ani-
mals with monoclonal antibody (IB4 , 1.5 mg/kg) decreased
CSF pleocytosis (consistent with previous observations [32])
but was associated with an increase in bacterial concentra-
tions in the CSF. Moreover, such pretreatment augmented
cerebral hyperemia in this model, and the increase in cere-
bral blood flow was correlated with increased bacterial titers
in CSF. Cerebrovascular autoregulation, as assessed by
blood-flow measurements at graded levels of hemorrhagic
hypotension, was preserved in Hib meningitis, but the capac-
ity for autoregulation was lost in infected IB4-treated ani-
mals. The discussion of this presentation focused on prob-
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lems with Hib as a pathogen in the rabbit model: this organ-
ism does not induce a universally lethal infection in this
model.
The use of transcranial Doppler (TCD) sonography in pa-
tients with bacterial meningitis was described by Hans-Peter
Haring (Innsbruck, Austria). Haring and his colleagues stud-
ied 110 patients with various infections of the CNS; 37% of
patients had bacterial infection, 24% had viral processes, and
39% had unclassified disease [70]. TCD sonography docu-
mented an increase ofblood-flow velocity in the middle cere-
bral artery in 77% of patients infected with pneumococci and
in 65% of those with meningococcal meningitis. Flow veloci-
ties were maximal 3-5 days into the illness and took 10-14
days to return to normal. Various causes of the observed
increase in flow velocity through the M I segment of the mid-
dle cerebral artery, including increased cerebral blood flow,
decreased vessel diameter, and decreased cerebrovascular pe-
ripheral resistance, were considered during the discussion of
this presentation. The contribution of these processes to the
documented result requires further study. The specificity of
the observation is also unknown. The impact of treatment
with dexamethasone or other adjunctive agents on the re-
sults of TCD sonography has not been studied.
Approaches to the Treatment of Bacterial Meningitis
Erich Schmutzhard (Innsbruck) reviewed the treatment of
bacterial meningitis with antimicrobial agents. Schmutzhard
questioned the value of heparin and raised the possibility of
administering cytokine antagonists. He discussed in some
depth the potential role of dexamethasone as an adjunct to
antimicrobial therapy for meningitis. A meta-analysis cover-
ing data from five studies on the subject has recently been
published [71]. All of the data were for cases in children and
supported the contention that rates of early and late neuro-
logical sequelae-particularly severe bilateral sensorineural
hearing loss-are reduced by concomitant therapy with dexa-
methasone. Nevertheless, only one clinical trial showed a
marked effect on both parameters [4], and the incidence of
neurological sequelae tended to be unusually high in the
control groups in these trials. Schmutzhard suggested that
further study of this issue was necessary. He also discussed
the possibility that third-generation cephalosporins are not
as efficacious as ampicillin and chloramphenicol in therapy
for bacterial meningitis because they exacerbate the inflam-
matory burst. The limitations of the data on dexamethasone
were considered during the discussion. The abandonment of
third-generation cephalosporins as empirical therapy for
meningitis in adults was not endorsed. Moreover, the recom-
mendation for a stepwise increase in the antibiotic dose used
in the treatment of pneumococcal disease did not meet with
favor among the clinicians in attendance.
Terry O'Reilly (Basel) presented the results of two studies.
The first described a rabbit model ofLPS-induced meningitis
that mimicked magnification of the inflammatory burst f(JI-
lowing antibiotic therapy. Meningitis was induced in rabbits
by intracisternal inoculation of 2.5 ng of LPS. The resulting
primary inflammation was followed 6 hours later by an injec-
tion of25 ng ofLPS. which produced a secondary inflamma-
tion simulating the accentuation of SAS inflammation after
antibiotic therapy. The administration of dexamethasone
(1.5 mg/kg iv) 15 minutes before the second injection ofLPS
inhibited the second peak of LPS-induced CSF inflamma-
tion. In addition. dexamethasone tended to reduce the sec-
ond peak in the TNF concentration in CSF following chal-
lenge with LPS. Somewhat surprisingly, brain levels ofTNF
mRNA after 7 hours were similar in dexamethasone-treated
rabbits and controls.
In another presentation. O'Reilly discussed adjunctive
treatment in an experimental animal model of meningitis
and reviewed the results of experiments conducted by Otto
Zak and colleagues [72. 73]. This series of studies charted
mortality and neurological sequelae in a large number of
rabbits in which pneumococcal meningitis was treated with
ampicillin and various anti-inflammatory agents. Treatment
was started 18 hours after infection. with all agents given
twice daily for 3 days. The mortality in the first 30 days was
clearly lowest among animals that received ampicillin (25
mg/kg) plus oxindanac (5 mg/kg). an experimen tal nonste-
roidal anti-inflammatory drug. rather than ampicillin alone.
ampicillin plus dexamethasone (I mg/kg). ampicillin plus
indomethacin (5 rug/kg). or no treatment. Although all an ti-
inflammatory drugs tended to reduce rates of neurological
sequelae, the results were best for ampicillin plus oxindanac.
The duration of neurological sequelae was also reduced bv
this combination. The discussion of this presentation fo-
cused on the mechanism( s} responsible for the observed re-
sults. A "weaker" nonsteroidal anti-inflammatory agent may
be more effective in this model. since indomethacin reduces
concentrations of prostaglandin E2 (PGE 2) in ('SF whereas
oxindanac does not. A reduction in PGE2 levels may actually
increase inflammation and therefore may be counterproduc-
tive.
The role of antibiotics other than iJ-Iactam agents in ther-
apy for pneumococcal meningitis was discussed by Martin
G. Tauber (San Francisco). When a series of quinolones
were evaluated in the rabbit model of experimental pneumo-
coccal meningitis. a good correlation was found between the
ratio of the peak CSF concentration to the MBC of the in-
fecting strain and the ultimate outcome of treatment.
CP 116,5 17 and temafloxacin were more effective in the erad-
ication of pneumococci from the CSF than was either ofloxa-
cin or ciprofloxacin. Somewhat surprisingly. the rate of kill-
ing in the CSF after the infusion ofrifampin was only ""-'0.25
logs per hour-much lower than that observed with maxi-
mally active iJ-lactam antibiotics-despite very favorable
MBC values for rifampin. Clarithromycin was generally inet-
fective despite peak CSF concentration-to-M BC' ratios of
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26-288. The ready entry of clarithromycin into CSF under-
scores the lack of activity of bacteriostatic agents in this in-
fection. The discussion of this presentation emphasized the
need for caution with the use of quinolones in the treatment
of meningitis. There was a general agreement that macro-
lides should not be used and some enthusiasm for the testing
of meropenem and other new carbapenems. Furthermore,
the discussion highlighted the critical importance of testing
"bactericidal" agents in vivo before using them in humans;
for example, clarithromycin may be bactericidal under some
circumstances in vitro but was clearly ineffective in the rab-
bit model. In addition, the degree ofCSF inflammation after
treatment with quinolones was very similar to that after
treatment with IJ-Iactams in this model of pneumococcal
meningitis; this similarity called into question the concept
that IJ-Iactams induce greater bacteriolysis and a more pro-
nounced inflammatory burst than other classes of antibi-
otics.
Finally, Hilmar Prange (Gottingen) discussed the appro-
priate use of ceftriaxone for the initial treatment of bacterial
meningitis. As 7%of all cases ofacute and subacute meningi-
tis in northern Germany are due to L. nionocvtogenes. the
empirical use of third-generation cephalosporins alone was
questioned. Prange emphasized the poor CSF penetration of
ceftriaxone despite CSF inflammation. Nevertheless, during
the discussion, the place of third-generation cephalosporins
in the empirical treatment of meningitis in adults-with the
addition ofampicillin to the regimen when L. inonocvtogenes
is a likely pathogen-was reaffirmed. The emergence ofceph-
alosporin-resistant, penicillin-resistant pneumococci may
dampen enthusiasm for this regimen in the future.
Areas for Future Research
The presentations at this workshop were summarized by
W. Michael Scheid (Charlottesville, Virginia, USA). The fol-
lowing topics were suggested as areas for fruitful research and
collaboration in the future.
( I) Identification and clarification of the bacterial signals
responsible for pathophysiological changes in the SAS are of
critical importance. Receptors within the SAS are obviously
capable of recognizing minimal alterations in putative bacte-
rial signals.
(2) The virulence factors responsible for bacterial entry,
survival, and multiplication within the CNS also require fur-
ther study. The genes and signals associated with the expres-
sion of these factors during the various phases of the disease
process are of interest.
(3) The putative neurotropism of bacterial pathogens
should be investigated further. At least three hypotheses
have been formulated; these hypotheses center on the role of
bacteremia and its magnitude, bacterial adhesion to CNS
sites, and bacterial entry (within macrophages) into the CNS,
respectively. The tools needed for relevant studies are at
hand.
(4) The interaction of bacteria and/or their components
with resident cells of the CNS in vitro is a fruitful area for
study. Many of the experiments described at the workshop
documented the interaction of bacteria with other cells, in-
cluding endothelial cells, astrocytes, and primary neurons in
culture. The influence of cell age, cell source, and many
other variables needs further scrutiny.
(5) The role of soluble cytokines in the pathophysiology
of meningitis seems certain, but the complex interplay of the
various cytokines clearly requires more study. IL-8 probably
plays a role and deserves further study as a synergistic cyto-
kine. Monoclonal antibodies to IL-8 and LPS should be stud-
ied together. The roles of IL-I 0 and other anticytokine or
noninflammatory cytokines later in the disease are of inter-
est. Monoclonal antibodies to TNF-O' may profoundly influ-
ence cerebral blood flow, CSF lactate levels, and other patho-
physiological parameters.
(6) The value of measurements ofCSF cytokine concen-
trations in the diagnosis of meningitis should be explored.
Data so far suggest that CSF concentrations of various cyto-
kines, including IL-I and TNF, rise in bacterial meningitis
(including partially treated bacterial meningitis) but not in
viral meningitis. Studies of the significance of the presence of
these cytokines in CSF from patients with fungal meningitis
are under way. The usefulness of measurements of IL-I 0 in
the discrimination of viral and bacterial meningitis (sug-
gested by data from Zurich) should be evaluated further. A
role for CSF concentrations ofelastase-o-I proteinase inhibi-
tor in the differential diagnosis of meningitis was suggested
by one study presented at the workshop.
(7) Leukocyte-endothelial cell interactions are at the
crux of inflammation. This finding is not unique to meningi-
tis, but the molecular biology of these interactions are of
critical importance to an understanding of this disease. Thus,
aspects unique to the CNS should be pursued. It would be
desirable to have immortalized brain endothelial cells in tis-
sue culture as a model for study. Obviously, such a model
would have to have all of the characteristics of endothelial
cells in vivo-a daunting requirement. Vascular addressins
unique to the CNS should be sought. The search for monoclo-
nal antibodies to inhibit CSF pleocytosis should be broad-
ened. IB4 is promising, but many other antibodies may be
useful.
(8) The mechanisms ofneuronal injury and the basic biol-
ogy of CSF inflammation and neuronal dysfunction are es-
sential elements in our understanding of the pathophysiol-
ogy of meningitis. These areas are already the focus of
research in several laboratories. The potential role of reactive
oxygen species, nitric oxide, and peroxynitrite in the patho-
physiology of meningitis was raised repeatedly during the
workshop. The fundamental interactions of these substances
with cytokines in meningitis (ifat all relevant) have not been
delineated. Reactive nitrogen species such as peroxynitrite
and other nitro groups on proteins should be measured in
CSF and in the CNS in situ. The role of SOD, PEG-SOD,
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and catalase in the treatment of meningitis should be as-
sessed.
(9) MRI is the procedure of choice for documentation of
the largely vascular complications of bacterial meningitis.
Nuclear MR spectroscopy, which is capable ofdetecting met-
abolic abnormalities (including lactate production in situ),
may be useful in furthering our understanding of anaerobic
metabolism during clinical meningitis.
(10) Several problems with specific agents used in antimi-
crobial therapy for meningitis remain. These include the fail-
ure of third-generation cephalosporins in the treatment of
gram-negative bacillary meningitis, the emergence of peni-
cillin-resistant pneumococci, the disturbing trend toward
higher MICs of third-generation cephalosporins against some
of these penicillin-resistant pneumococci, and the persis-
tently high mortality rates associated with meningitis due to
many bacterial pathogens. Determination of the role ofquin-
olones and carbapenerns, among other agents, requires test-
ing in animal models and, where appropriate, in humans.
(11) Prospective studies ofadjunctive management strate-
gies for bacterial meningitis should be conducted. These strat-
egies involve not only steroids but also phenytoin (for pro-
phylaxis, as studied recently in Spain), mannitol or glycerol
(as assessed in recent clinical trials in Finland), and heparin
(as discussed by Schmutzhard and others). Other adjunctive
strategies-such as the systemic administration of monoclo-
nal antibodies to reduce CSF pleocytosis; the use ofcombina-
tions of monoclonal antibodies with dexamethasone; and
treatment with scavengers of reactive oxygen species, nitric
oxide, and/or peroxynitrite-should be tested in animal
models. If appropriate in light of experimental results in ani-
mals, sequential and/or combination adjunctive therapies
may be explored in patients. Insights into the pathophysiol-
ogy of CSF inflammation may be forthcoming from these
studies. Although these strategies are clearly not the answer
to the continuing problem of meningitis in developing coun-
tries and are potentially expensive, their evaluation will yield
further information relevant to CNS inflammation, neurolog-
ical dysfunction, and neurosciences in general.
Challenges for the Future
Several challenges for the future were formulated at the
close of the workshop. (1) Increased collaboration between
basic scientists and clinical researchers at multiple laborato-
ries is essential. The valuable exchange of information at this
meeting-in both formal and informal settings-should
continue. (2) Increased collaboration is also needed among
investigators in prospective, multicenter, international stud-
ies of new adjunctive and antimicrobial treatment modali-
ties. (3) Given the pace ofprogress in this field, another meet-
ing should be held in """-' 3 years. We hope that this review will
stimulate research that will lead to important advances in the
coming years.
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